Abstract:Traditional Chinese medicine improves cardiovascular diseases by inhibiting energy deficit, oxidative stress, excessive apoptosis and inflammation through regulating fatty acid metabolism. Cardiovascular diseases are currently the primary cause of mortality in the whole world. Growing evidence indicated that the disturbances in cardiac fatty acid metabolism are crucial contributors in the development of cardiovascular diseases. The abnormal cardiac fatty acid metabolism usually leads to energy deficit, oxidative stress, excessive apoptosis, and inflammation. Targeting fatty acid metabolism has been regarded as a novel approach to the treatment of cardiovascular diseases. However, there are currently no specific drugs that regulate fatty acid metabolism to treat cardiovascular diseases. Many traditional Chinese medicines have been widely used to treat cardiovascular diseases in clinics. And modern studies have shown that they exert a cardioprotective effect by regulating the expression of key proteins involved in fatty acid metabolism, such as peroxisome proliferator‐activated receptor α and carnitine palmitoyl transferase 1. Hence, we systematically reviewed the relationship between fatty acid metabolism disorders and four types of cardiovascular diseases including heart failure, coronary artery disease, cardiac hypertrophy, and diabetic cardiomyopathy. In addition, 18 extracts and eight monomer components from traditional Chinese medicines showed cardioprotective effects by restoring cardiac fatty acid metabolism. This work aims to provide a reference for the finding of novel cardioprotective agents targeting fatty acid metabolism.

Microelements and Cardiovascular Diseases

Gut microbiota and microbiota-derived metabolites in cardiovascular diseases

Coronary microvascular dysfunction and cardiovascular disease: Pathogenesis, associations and treatment strategies

Metallothionein and Cardiovascular Diseases

Gut Microbiota: A Novel Regulator of Cardiovascular Disease and Key Factor in the Therapeutic Effects of Flavonoids

Environmental heavy metals and cardiovascular diseases: Status and future direction

How Do Minerals, Vitamins, and Intestinal Microbiota Affect the Development and Progression of Heart Disease in Adult and Pediatric Patients?

Fatty acid metabolism disorders and potential therapeutic traditional Chinese medicines in cardiovascular diseases

An Emerging Role of Defective Copper Metabolism in Heart Disease

Interactions Between Therapeutics for Metabolic Disease, Cardiovascular Risk Factors, and Gut Microbiota

Immunity specificity determinants in the P4-like retronphage phi R73.

On polynomial interpolation to analytic functions with singularities

Role of Iron-Related Oxidative Stress and Mitochondrial Dysfunction in Cardiovascular Diseases

Implication of Gut Microbiota in Cardiovascular Diseases

Immune mechanism of gut microbiota and its metabolites in the occurrence and development of cardiovascular diseases

Antioxidant Food Components for the Prevention and Treatment of Cardiovascular Diseases: Effects, Mechanisms, and Clinical Studies

Microbiota-derived short-chain fatty acids: Implications for cardiovascular and metabolic disease

Role and mechanism of miRNA in cardiac microvascular endothelial cells in cardiovascular diseases

Acute paralytic disease in Japan

Gut Microbes in Cardiovascular Diseases and Their Potential Therapeutic Applications

Gut microbiota metabolites as integral mediators in cardiovascular diseases (Review)